Carbapenem derivative containing guanidyl alkanoylamino heterocycle

An azabicycle and methyl technology, which can be used in medical preparations containing active ingredients, organic chemistry, organic active ingredients, etc., can solve the problems of increased drug resistance and low clinical availability.

Active Publication Date: 2011-01-12
XUANZHU BIOPHARMACEUTICAL CO LTD
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The clinical efficacy of carbapenem antibiotics is excellent, but with the increase of clinical application, drug resistance increases, and the currently marketed penem antibiotics can only be administered as injections in clinical practice, and the clinical utilization is not high

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Carbapenem derivative containing guanidyl alkanoylamino heterocycle
  • Carbapenem derivative containing guanidyl alkanoylamino heterocycle
  • Carbapenem derivative containing guanidyl alkanoylamino heterocycle

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

Embodiment 2

Embodiment 3

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the technical field of medicine, and in particular relates to a carbapenem derivative containing guanidyl alkane amido heterocycle as shown in the general formula (I), a pharmaceutically acceptable salt thereof, and an easily-hydrolytic ester thereof or an isomer thereof, wherein R<1>, R<2>, R<3>, R<4>, R<5>, R<6>, R<7>, R<8> and X are as defined in the instruction. The invention also relates to a method for preparing the compounds, a pharmaceutical composition containing the compounds, as well as application of the compounds in the preparation of drugs for treating and / or preventing infectious diseases.

Description

1. Technical field The invention belongs to the field of medical technology, and in particular relates to carbapenem derivatives containing a guanidinoalkanoyl amido heterocycle, pharmaceutically acceptable salts thereof, easily hydrolyzed esters or isomers thereof, and methods for preparing these compounds. A pharmaceutical composition containing these compounds, and the application of these compounds in the preparation of medicines for treating and / or preventing infectious diseases. 2. Background technology Carbapenem antibiotics are new broad-spectrum, enzyme-resistant and highly effective β-lactam antibiotics developed in the 1970s. In 1976, Thiamycin, the first carbapenem antibiotic, was discovered, but it was not used clinically due to its poor chemical stability. Later, the chemical structure modification of thiamycin produced a series of carbapenem derivatives. Drugs of this type currently on the market include imipenem, panipenem, meropenem, doripenem, biapenem, a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C07D477/20A61K31/427A61K31/433A61P31/04
CPCY02P20/55
Inventor 黄振华
Owner XUANZHU BIOPHARMACEUTICAL CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products